Dexmedetomidine for prevention of skeletal muscle ischaemia-reperfusion injury in patients with chronic limb ischaemia undergoing aortobifemoral bypass surgery: A prospective double-blind randomized controlled study
Annals of Cardiac Anaesthesia Jan 28, 2018
Kundra TS, et al. - Dexmedetomidine, a selective α-2 agonist, was tested as a prophylactic for skeletal muscle ischemia-reperfusion injury in patients undergoing aortobifemoral bypass surgery. Researchers found that dexmedetomidine prevented skeletal muscle ischemia-reperfusion injury in this patient population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
